A

Apogenix Ltd

28 employees

Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.

Basic info

biotechnology research

Biotechnology

Drug candidates for cancer treatment

Therapeutics

Glioblastoma

CD95

COVID-19

Development of immunotherapeutics

Myelodysplastic syndromes

TNF superfamily signaling

Health Care

2005

$3.3M

from 1 investors over 1 rounds

A

Apogenix Ltd raised $3.3M on February 16, 2016

Investors: Federal Ministry of Education and Research, Germany